EUVIMEDEUVIMED entdecken
Open Access

Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application

Rama Kashikar, Samir Senapati, Narendar Dudhipala, Sandip K Basu, Nawajes Mandal, Soumyajit Majumdar

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2024.0055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Rama Kashikar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Drug Delivery, University of Mississippi, Mississippi, USA. Hauptthemen laut MEDLINE: Emulsions, Fingolimod Hydrochloride, Rats, Sprague-Dawley, Administration, Ophthalmic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Fingolimod (FTY720; FT), a structural analog of sphingosine, has potential ocular applications. The goal of this study was to develop an FT-loaded nanoemulsion (NE; FT-NE) formulation for the efficient and prolonged delivery of FT to the posterior segment of the eye through the topical route.

Methods

FT-NE formulations were prepared using homogenization followed by the probe sonication method. The lead FT-NE formulations (0.15% and 0.3% w/v loading), comprising soybean oil as oil and Tween ® 80 and Poloxamer 188 as surfactants, were further evaluated for in vitro release, surface morphology, filtration sterilization, and stability at refrigerated temperature. Ocular bioavailability following topical application of FT-NE (0.3%) was examined in Sprague-Dawley rats.

Results

The formulation, at both dose levels, showed desirable physicochemical characteristics, a nearly spherical shape with homogenous nanometric size distribution, and was stable for 180 days (last time point checked) at refrigerated temperature postfiltration through a polyethersulfone (0.22 µm) membrane. In vitro release studies showed prolonged release over 24 h, compared with the control FT solution (FT-S). In vivo studies revealed that effective concentrations of FT were achieved in the vitreous humor and retina following topical application of FT-NE.

Conclusions

The results from these studies demonstrate that the FT-NE formulation can serve as a viable platform for the ocular delivery of FT through the topical route.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EmulsionsFingolimod HydrochlorideRats, Sprague-DawleyAdministration, OphthalmicAnimalsRatsMaleBiological AvailabilityOphthalmic SolutionsImmunosuppressive AgentsAdministration, TopicalNanoparticlesPolysorbatesPoloxamerDrug Delivery SystemsDrug StabilitySurface-Active Agents

Stichwörter der Autor:innen

and physicochemical characterizationfingolimodnanoemulsionocular drug deliverystabilitysterilization

Substanzen

EmulsionsFingolimod HydrochlorideOphthalmic SolutionsImmunosuppressive AgentsPolysorbatesPoloxamerSurface-Active Agents

Autor:innen und Institutionen

  • Department of Pharmaceutics and Drug Delivery, University of Mississippi, Mississippi, USA.
  • Department of Ophthalmology, The University of Tennessee Health Science Center, Hamilton Eye Institute, Memphis, Tennessee, USA.
  • Department of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Research Institute of Pharmaceutical Sciences, University of Mississippi, Mississippi, USA.

Förderung

  • NEI NIH HHS

Zitieren

APA

Kashikar, R., Senapati, S., Dudhipala, N., Basu, S. K., Mandal, N., & Majumdar, S. (2024). Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0055

Vancouver

Kashikar R, Senapati S, Dudhipala N, Basu SK, Mandal N, Majumdar S. Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0055

BibTeX
@article{Kashikar2024,
  author = {Kashikar, Rama and Senapati, Samir and Dudhipala, Narendar and Basu, Sandip K and Mandal, Nawajes and Majumdar, Soumyajit},
  title = {Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2024.0055}
}
Kostenlos starten →